NO173389C - Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater - Google Patents
Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivaterInfo
- Publication number
- NO173389C NO173389C NO872885A NO872885A NO173389C NO 173389 C NO173389 C NO 173389C NO 872885 A NO872885 A NO 872885A NO 872885 A NO872885 A NO 872885A NO 173389 C NO173389 C NO 173389C
- Authority
- NO
- Norway
- Prior art keywords
- tetrapeutically
- tritian
- intermediates
- derivatives
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D341/00—Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO921307A NO175099C (no) | 1986-07-15 | 1992-04-03 | Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16616786 | 1986-07-15 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO872885D0 NO872885D0 (no) | 1987-07-10 |
| NO872885L NO872885L (no) | 1988-01-18 |
| NO173389B NO173389B (no) | 1993-08-30 |
| NO173389C true NO173389C (no) | 1993-12-08 |
Family
ID=15826315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO872885A NO173389C (no) | 1986-07-15 | 1987-07-10 | Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4816475A (no) |
| EP (1) | EP0253370B1 (no) |
| JP (1) | JPS63146870A (no) |
| KR (1) | KR950003499B1 (no) |
| AU (1) | AU596434B2 (no) |
| CA (1) | CA1296728C (no) |
| DE (1) | DE3788163T2 (no) |
| DK (1) | DK365087A (no) |
| FI (1) | FI90075C (no) |
| HU (1) | HUT46904A (no) |
| IE (1) | IE60984B1 (no) |
| IL (1) | IL83171A (no) |
| NO (1) | NO173389C (no) |
| NZ (1) | NZ221032A (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8728235D0 (en) * | 1987-12-02 | 1988-01-06 | Sandoz Ltd | Novel azole compounds |
| US5149844A (en) * | 1989-10-20 | 1992-09-22 | Air Products And Chemicals, Inc. | Heterocyclic diorganotin catalysts for use in polyurethane systems |
| CN103003268A (zh) | 2010-07-19 | 2013-03-27 | 先正达参股股份有限公司 | 作为杀微生物剂的异噁唑、异噻唑、呋喃以及噻吩化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3492313A (en) * | 1967-01-16 | 1970-01-27 | Pfizer & Co C | Novel derivatives of 1,3,5-trithiane |
| US3525751A (en) * | 1967-03-27 | 1970-08-25 | Syntex Corp | Hormonal diphenyl methylol and benzhydrylidene derivatives |
| US3792043A (en) * | 1971-12-02 | 1974-02-12 | Squibb & Sons Inc | Process for converting compounds containing a cyclic sulfur group to aldehydes or ketones |
| JPS5748980A (en) * | 1980-09-05 | 1982-03-20 | Mitsubishi Chem Ind Ltd | Cyclopropanecarboxylic ester |
| ZA821644B (en) * | 1981-03-25 | 1983-01-26 | Expansia Sa | Borane complexes |
-
1987
- 1987-07-10 NZ NZ221032A patent/NZ221032A/xx unknown
- 1987-07-10 NO NO872885A patent/NO173389C/no unknown
- 1987-07-13 IL IL83171A patent/IL83171A/xx not_active IP Right Cessation
- 1987-07-14 EP EP87110180A patent/EP0253370B1/en not_active Expired - Lifetime
- 1987-07-14 IE IE190287A patent/IE60984B1/en not_active IP Right Cessation
- 1987-07-14 HU HU873210A patent/HUT46904A/hu unknown
- 1987-07-14 DE DE87110180T patent/DE3788163T2/de not_active Expired - Fee Related
- 1987-07-14 US US07/073,449 patent/US4816475A/en not_active Expired - Fee Related
- 1987-07-14 JP JP62175640A patent/JPS63146870A/ja active Pending
- 1987-07-14 DK DK365087A patent/DK365087A/da not_active Application Discontinuation
- 1987-07-14 FI FI873116A patent/FI90075C/fi not_active IP Right Cessation
- 1987-07-14 CA CA000542009A patent/CA1296728C/en not_active Expired - Fee Related
- 1987-07-15 AU AU75680/87A patent/AU596434B2/en not_active Ceased
- 1987-07-15 KR KR1019870007666A patent/KR950003499B1/ko active IP Right Grant
-
1988
- 1988-10-17 US US07/258,667 patent/US5045562A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3788163T2 (de) | 1994-03-10 |
| US4816475A (en) | 1989-03-28 |
| NO173389B (no) | 1993-08-30 |
| DK365087D0 (da) | 1987-07-14 |
| KR880001629A (ko) | 1988-04-25 |
| CA1296728C (en) | 1992-03-03 |
| AU7568087A (en) | 1988-01-21 |
| NO872885L (no) | 1988-01-18 |
| NZ221032A (en) | 1990-02-26 |
| IL83171A0 (en) | 1987-12-31 |
| HUT46904A (en) | 1988-12-28 |
| IE871902L (en) | 1988-01-15 |
| FI90075B (fi) | 1993-09-15 |
| DE3788163D1 (de) | 1993-12-23 |
| KR950003499B1 (ko) | 1995-04-13 |
| NO872885D0 (no) | 1987-07-10 |
| EP0253370A1 (en) | 1988-01-20 |
| IE60984B1 (en) | 1994-09-07 |
| DK365087A (da) | 1988-01-16 |
| FI90075C (fi) | 1993-12-27 |
| FI873116A0 (fi) | 1987-07-14 |
| EP0253370B1 (en) | 1993-11-18 |
| JPS63146870A (ja) | 1988-06-18 |
| IL83171A (en) | 1992-07-15 |
| US5045562A (en) | 1991-09-03 |
| AU596434B2 (en) | 1990-05-03 |
| FI873116A (fi) | 1988-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO871640L (no) | Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater. | |
| NO870579L (no) | Fremgangsmaate for fremstilling av indolizin-derivater. | |
| NO862650L (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
| NO173653C (no) | Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner | |
| TR23424A (tr) | 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri | |
| FI894546A (fi) | Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi | |
| NO890661D0 (no) | Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO173389C (no) | Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater | |
| FI860247A0 (fi) | Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner. | |
| NO882336D0 (no) | Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener. | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO874199D0 (no) | Fremgangsmaate for fremstilling av imidazo-pyridinonderivater. | |
| NO871484L (no) | Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider. | |
| NO873353D0 (no) | Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater. | |
| FI904673A0 (fi) | 2,6-dioksopiperidiinijohdannaisten valmistus | |
| NO874698D0 (no) | Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater. | |
| NO861178L (no) | Fremgangsmaate for fremstilling av 1,8-nafthyridinoner. | |
| NO864305L (no) | Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO922253L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater | |
| NO922254D0 (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater | |
| NO873019D0 (no) | Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater. | |
| LV5470A3 (lv) | 3-(2,2-Difluorbenzodioksol-4-il)-4-cianpirola iegusanas panemiens | |
| NO175099C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater | |
| RO92582A (ro) | Procedeu pentru prepararea unor 5,6-dialcoxi-4-alchil-2(1h)-chinazolinone |